6.13. Analysis.
Comparison 6 ICS versus placebo, studies of COPD with BHR, greater than 6 months (all doses), Outcome 13 Change in post‐bronchodilator FEV1 (mL/yr).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.